Back to top
more

Hologic (HOLX)

(Delayed Data from NSDQ)

$67.81 USD

67.81
4,181,054

-0.25 (-0.37%)

Updated Aug 15, 2025 04:00 PM ET

After-Market: $67.84 +0.03 (0.04%) 6:44 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (158 out of 246)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Here's Why You Should Retain Catalent (CTLT) Stock for Now

by Zacks Equity Research

Catalent's (CTLT) product and service launches and a slew of strategic deals raise optimism about the stock.

Zacks Equity Research

Cardinal Health's (CAH) New Tie-Up to Boost Patient Outcomes

by Zacks Equity Research

Cardinal Health's (CAH) latest partnership is expected to improve patients' healthcare journey by offering a more integrated experience that connects all sites of care.

Zacks Equity Research

Three Reasons to Add BD (BDX) Stock to Your Portfolio Now

by Zacks Equity Research

Investors continue to be optimistic about BD (BDX) owing to a few regulatory approvals and product launches.

Zacks Equity Research

HOLX or EW: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

HOLX vs. EW: Which Stock Is the Better Value Option?

Zacks Equity Research

Here's Why You Should Retain Surmodics (SRDX) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Surmodics (SRDX) owing to its solid prospects in the thrombectomy business.

Zacks Equity Research

Walgreens Boots (WBA) Benefits From New Launches Amid FX Woes

by Zacks Equity Research

Walgreens Boots' (WBA) comparable pharmacy sales decline, reflecting lower demand for COVID-19 services.

Zacks Equity Research

Hologic (HOLX) Down 5.2% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Hologic (HOLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Cooper Companies (COO) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Cooper Companies' (COO) first-quarter fiscal 2023 revenues reflect a solid segmental performance despite a year-over-year decline in earnings.

Zacks Equity Research

Haemonetics (HAE) Autotransfusion System Gets 510(k) Clearance

by Zacks Equity Research

The latest development is expected to upgrade Haemonetics' (HAE) Cell Salvage platform and broaden the company's scope in the growing autotransfusion space.

Zacks Equity Research

NextGen (NXGN) Behavioral Health Suite Adopted by Compass Health

by Zacks Equity Research

NextGen's (NXGN) Behavioral Health Suite is expected to aid Compass Health in improving its workflow.

Zacks Equity Research

Zacks.com featured highlights AutoNation, CNH Industrial, Valero Energy, Hologic and Ryder System

by Zacks Equity Research

AutoNation, CNH Industrial, Valero Energy, Hologic and Ryder System have been highlighted in this Screen of The Week article.

Zacks Equity Research

Hologic (HOLX) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Hologic (HOLX) closed at $80.08 in the latest trading session, marking a +1.29% move from the prior day.

Zacks Equity Research

Veeva Systems (VEEV) Q4 Earnings Beat, Margins Decline

by Zacks Equity Research

Veeva Systems' (VEEV) Q4 results reflect impressive performances by both segments.

Zacks Equity Research

National Vision (EYE) Q4 Revenues Miss Mark, Margins Down

by Zacks Equity Research

National Vision (EYE) is facing a challenging macroeconomic environment, which negatively impacted its performance in the fourth quarter of 2022.

Zacks Equity Research

Patterson Companies (PDCO) Q3 Earnings Beat, Sales Hurt by FX

by Zacks Equity Research

Patterson Companies' (PDCO) fiscal third-quarter 2023 results are negatively impacted by unfavorable currency movements.

Supriyo Bose headshot

Top 5 Stocks With High ROE as Equity Markets Flop in February

by Supriyo Bose

AutoNation (AN), CNH Industrial (CNHI), Valero (VLO), Hologic (HOLX) and Ryder (R) are some of the stocks with high ROE to profit from as equity markets decline in February.

Zacks Equity Research

Here's Why You Should Invest in Hologic (HOLX) Stock Now

by Zacks Equity Research

Investors are optimistic about Hologic (HOLX) on the continued strength of GYN Surgical and Breast Health businesses.

Zacks Equity Research

Myriad Genetics (MYGN) Q4 Earnings Top, Gross Margin Falls

by Zacks Equity Research

Myriad Genetics (MYGN) hereditary cancer testing volume registered strong growth in the fourth quarter. GeneSight comes up with yet another strong performance.

Zacks Equity Research

Hologic's (HOLX) Strategic Buyouts Aid, Surgical Arm Grows

by Zacks Equity Research

Hologic's (HOLX) GYN Surgical results underscore a more diverse surgical business with more growth drivers than in the past.

Zacks Equity Research

Masimo (MASI) Q4 Earnings Surpass Estimates, Margins Down

by Zacks Equity Research

Masimo's (MASI) robust product shipments and continued strength in its healthcare business drive its Q4 sales.

Zacks Equity Research

Inari Medical (NARI) Q4 Earnings Beat, Revenues Rise Y/Y

by Zacks Equity Research

Inari Medical's (NARI) fourth-quarter results benefit from significant progress made across all its growth drivers.

Zacks Equity Research

DENTSPLY SIRONA (XRAY) Q4 Earnings & Revenues Beat Estimates

by Zacks Equity Research

DENTSPLY SIRONA's (XRAY) Q4 earnings and revenues decline year over year due to unfavorable foreign currency movement and soft demand across all geographical segments.

Zacks Equity Research

PerkinElmer's (PKI) Latest Launch to Boost Research Workflows

by Zacks Equity Research

PerkinElmer's (PKI) latest launch is expected to provide increased assay flexibility to researchers.

Zacks Equity Research

Reasons to Add Quest Diagnostics (DGX) Stock to Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about Quest Diagnostics (DGX) on its accelerated growth strategy and improvements in base volumes.

Zacks Equity Research

Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.